In the U.K., patients have begun receiving a brand new gene therapy that will halt sight loss due to retinal dystrophy as a result of inheriting a faulty copy of the RPE65 gene from both parents. The injection, made into the back of the eye, delivers working copies of the RPE65 gene. Head over to the BBC to learn more about this life changing new treatment.